Fulgent Genetics, Inc. (FLGT) president reports 4,361-share tax withholding
Rhea-AI Filing Summary
Fulgent Genetics, Inc. President and COO Jian Xie reported a tax‑withholding disposition of 4,361 shares of common stock on July 26, 2026, at $19.67 per share, to cover taxes from vesting restricted stock units. After this, he directly held 363,244 shares, with an additional 220,816 shares held indirectly through The Hsieh Family Dynasty Trust, where he serves on the investment committee and disclaims beneficial interest except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,361 shares
Net Sell
2 txns
Insider
Xie Jian
Role
President and COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1 | 4,361 | $19.67 | $86K |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 363,244 shares (Direct);
Common Stock — 220,816 shares (Indirect, By Trust)
Footnotes (2)
- F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
- F2. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Key Figures
Shares withheld for taxes: 4,361 shares
Withholding price per share: $19.67 per share
Direct holdings after transaction: 363,244 shares
+1 more
4 metrics
Shares withheld for taxes
4,361 shares
Common stock withheld on July 26, 2026 to satisfy tax withholding obligations from RSU vesting
Withholding price per share
$19.67 per share
Value used for the 4,361-share tax-withholding disposition on July 26, 2026
Direct holdings after transaction
363,244 shares
Jian Xie’s directly owned Fulgent Genetics common shares following the tax-withholding transaction
Indirect trust holdings
220,816 shares
Shares held by The Hsieh Family Dynasty Trust, where Jian Xie serves on the investment committee
Key Terms
restricted stock units, tax withholding obligations, pecuniary interest, investment committee
4 terms
restricted stock units financial
"upon the vesting of certain restricted stock units assumed"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy the tax withholding obligations that arose"
pecuniary interest financial
"disclaims any beneficial interest except with respect to any pecuniary interest"
investment committee financial
"Mr. Xie serves on the investment committee of the Trust"
An investment committee is a small group of experienced people who set the rules and make the key decisions about what investments to buy, hold, or sell for a fund, pension, or portfolio. Think of them as the steering team that balances goals, potential returns and risk—their choices shape how much money investors are likely to gain or lose and provide consistent oversight so decisions aren’t made impulsively.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Fulgent Genetics (FLGT) report for Jian Xie?
Fulgent Genetics reported that President and COO Jian Xie had 4,361 shares of common stock withheld on July 26, 2026 at $19.67 per share. The shares were used to satisfy tax withholding obligations from vesting restricted stock units assumed in a prior merger.
Was Jian Xie’s FLGT Form 4 transaction an open-market sale?
No, Jian Xie’s reported transaction was a tax-withholding disposition, not an open-market sale. 4,361 shares were withheld by the issuer to cover taxes due upon RSU vesting, as described in the footnote, rather than being sold on the market.
What is the role of The Hsieh Family Dynasty Trust in Jian Xie’s FLGT holdings?
The Hsieh Family Dynasty Trust holds 220,816 Fulgent Genetics shares as an indirect holding for Jian Xie. He serves on the Trust’s investment committee and disclaims beneficial interest except for any pecuniary interest, according to the Form 4 footnote.
Is Jian Xie’s FLGT Form 4 transaction under a Rule 10b5-1 trading plan?
The Form 4 indicates the transaction was not made under a Rule 10b5-1 trading plan. The filing’s 10b5‑1 checkbox is explicitly unchecked, distinguishing this tax-withholding disposition from trades executed pursuant to a pre-arranged trading plan.